NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Dahabreh IJ, Moorthy D, Lamont JL, et al. Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Sep. (Comparative Effectiveness Reviews, No. 125.)
Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment [Internet].
Show detailsAppendix Table D1. Descriptive characteristics of studies reporting analytic validity information for CYP2C19 assays (MS Word, 38K)
Appendix Table D2. Reporting characteristics and methodological quality of studies of analytic validity (MS Word, 54K)
Appendix Table D3. Descriptive characteristics of included studies (MS Word, 74K)
Appendix Table D4. Study design characteristics (MS Word, 56K)
Appendix Table D5. Genotypic test information (MS Word, 100K)
Appendix Table D6. Methods for reactivity assessment (used for outcome ascertainment) (MS Word, 85K)
Appendix Table D7. Clinical outcome information – mortality (MS Word, 65K)
Appendix Table D8. Clinical outcome information – myocardial infarction (MS Word, 64K)
Appendix Table D9. Clinical outcome information – stent thrombosis (MS Word, 82K)
Appendix Table D10. Clinical outcome information – major adverse cardiovascular events (MS Word, 107K)
Appendix Table D11. Clinical outcome information – bleeding (MS Word, 82K)
Appendix Table D12. Clinical outcome information – stroke (MS Word, 56K)
Appendix Table D13. Clinical outcome information – other clinical events (MS Word, 60K)
Appendix Table D14. Platelet reactivity during followup (discrete outcome) (MS Word, 139K)
Appendix Table D15. Platelet reactivity during followup (continuous outcome) (MS Word, 234K)
Appendix Table D16. Quality assessment (MS Word, 83K)
- Appendix Tables for Key Question 1 - Testing of CYP2C19 Variants and Platelet Re...Appendix Tables for Key Question 1 - Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment
- Effectiveness of Treatments for Menopausal Symptoms in Selected Subgroups - Meno...Effectiveness of Treatments for Menopausal Symptoms in Selected Subgroups - Menopausal Symptoms: Comparative Effectiveness of Therapies
- Evidence Tables for Sublingual Immunotherapy - Allergen-Specific Immunotherapy f...Evidence Tables for Sublingual Immunotherapy - Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review
- Trichosporon inkin strain V23 internal transcribed spacer 1, partial sequence; 5...Trichosporon inkin strain V23 internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA gene, complete sequence; and internal transcribed spacer 2, partial sequencegi|1005506894|gb|KT900113.1|Nucleotide
- Trichosporon inkin strain V20 internal transcribed spacer 1, partial sequence; 5...Trichosporon inkin strain V20 internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA gene, complete sequence; and internal transcribed spacer 2, partial sequencegi|1005506893|gb|KT900112.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...